Cargando…

Disposing of Excess Vaccines After the Withdrawal of Oral Polio Vaccine

Until recently, waste management for national immunization programs was limited to sharps waste, empty vaccine vials, or vaccines that had expired or were no longer usable. However, because wild-type 2 poliovirus has been eradicated, the World Health Organization’s (WHO’s) Strategic Advisory Group o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wanyoike, Sarah, Ramirez Gonzalez, Alejandro, Dolan, Samantha B., Garon, Julie, Veira, Chantal Laroche, Hampton, Lee M., Chang Blanc, Diana, Patel, Manish M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853297/
https://www.ncbi.nlm.nih.gov/pubmed/28838168
http://dx.doi.org/10.1093/infdis/jiw572
_version_ 1783306736629710848
author Wanyoike, Sarah
Ramirez Gonzalez, Alejandro
Dolan, Samantha B.
Garon, Julie
Veira, Chantal Laroche
Hampton, Lee M.
Chang Blanc, Diana
Patel, Manish M.
author_facet Wanyoike, Sarah
Ramirez Gonzalez, Alejandro
Dolan, Samantha B.
Garon, Julie
Veira, Chantal Laroche
Hampton, Lee M.
Chang Blanc, Diana
Patel, Manish M.
author_sort Wanyoike, Sarah
collection PubMed
description Until recently, waste management for national immunization programs was limited to sharps waste, empty vaccine vials, or vaccines that had expired or were no longer usable. However, because wild-type 2 poliovirus has been eradicated, the World Health Organization’s (WHO’s) Strategic Advisory Group of Experts on Immunization deemed that all countries must simultaneously cease use of the type 2 oral polio vaccine and recommended that all countries and territories using oral polio vaccine (OPV) “switch” from trivalent OPV (tOPV; types 1, 2, and 3 polioviruses) to bivalent OPV (bOPV; types 1 and 3 polioviruses) during a 2-week period in April 2016. Use of tOPV after the switch would risk outbreaks of paralysis related to type 2–circulating vaccine-derived poliovirus (cVDPV2). To minimize risk of vaccine-derived polio countries using OPV were asked to dispose of all usable, unexpired tOPV after the switch to bOPV. In this paper, we review the rationale for tOPV disposal and describe the global guidelines provided to countries for the safe and appropriate disposal of tOPV. These guidelines gave countries flexibility in implementing this important task within the confines of their national regulations, capacities, and resources. Steps for appropriate disposal of tOPV included removal of all tOPV vials from the cold chain, placement in appropriate bags or containers, and disposal using a recommended approach (ie, autoclaving, boiling, chemical inactivation, incineration, or encapsulation) followed by burial or transportation to a designated waste facility. This experience with disposal of tOPV highlights the adaptability of national immunization programs to new procedures, and identifies gaps in waste management policies and strategies with regard to disposal of unused vaccines. The experience also provides a framework for future policies and for developing programmatic guidance for the ultimate disposal of all OPV after the eradication of polio.
format Online
Article
Text
id pubmed-5853297
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-58532972018-03-23 Disposing of Excess Vaccines After the Withdrawal of Oral Polio Vaccine Wanyoike, Sarah Ramirez Gonzalez, Alejandro Dolan, Samantha B. Garon, Julie Veira, Chantal Laroche Hampton, Lee M. Chang Blanc, Diana Patel, Manish M. J Infect Dis Supplement Article Until recently, waste management for national immunization programs was limited to sharps waste, empty vaccine vials, or vaccines that had expired or were no longer usable. However, because wild-type 2 poliovirus has been eradicated, the World Health Organization’s (WHO’s) Strategic Advisory Group of Experts on Immunization deemed that all countries must simultaneously cease use of the type 2 oral polio vaccine and recommended that all countries and territories using oral polio vaccine (OPV) “switch” from trivalent OPV (tOPV; types 1, 2, and 3 polioviruses) to bivalent OPV (bOPV; types 1 and 3 polioviruses) during a 2-week period in April 2016. Use of tOPV after the switch would risk outbreaks of paralysis related to type 2–circulating vaccine-derived poliovirus (cVDPV2). To minimize risk of vaccine-derived polio countries using OPV were asked to dispose of all usable, unexpired tOPV after the switch to bOPV. In this paper, we review the rationale for tOPV disposal and describe the global guidelines provided to countries for the safe and appropriate disposal of tOPV. These guidelines gave countries flexibility in implementing this important task within the confines of their national regulations, capacities, and resources. Steps for appropriate disposal of tOPV included removal of all tOPV vials from the cold chain, placement in appropriate bags or containers, and disposal using a recommended approach (ie, autoclaving, boiling, chemical inactivation, incineration, or encapsulation) followed by burial or transportation to a designated waste facility. This experience with disposal of tOPV highlights the adaptability of national immunization programs to new procedures, and identifies gaps in waste management policies and strategies with regard to disposal of unused vaccines. The experience also provides a framework for future policies and for developing programmatic guidance for the ultimate disposal of all OPV after the eradication of polio. Oxford University Press 2017-07-01 2017-06-30 /pmc/articles/PMC5853297/ /pubmed/28838168 http://dx.doi.org/10.1093/infdis/jiw572 Text en © The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Supplement Article
Wanyoike, Sarah
Ramirez Gonzalez, Alejandro
Dolan, Samantha B.
Garon, Julie
Veira, Chantal Laroche
Hampton, Lee M.
Chang Blanc, Diana
Patel, Manish M.
Disposing of Excess Vaccines After the Withdrawal of Oral Polio Vaccine
title Disposing of Excess Vaccines After the Withdrawal of Oral Polio Vaccine
title_full Disposing of Excess Vaccines After the Withdrawal of Oral Polio Vaccine
title_fullStr Disposing of Excess Vaccines After the Withdrawal of Oral Polio Vaccine
title_full_unstemmed Disposing of Excess Vaccines After the Withdrawal of Oral Polio Vaccine
title_short Disposing of Excess Vaccines After the Withdrawal of Oral Polio Vaccine
title_sort disposing of excess vaccines after the withdrawal of oral polio vaccine
topic Supplement Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853297/
https://www.ncbi.nlm.nih.gov/pubmed/28838168
http://dx.doi.org/10.1093/infdis/jiw572
work_keys_str_mv AT wanyoikesarah disposingofexcessvaccinesafterthewithdrawaloforalpoliovaccine
AT ramirezgonzalezalejandro disposingofexcessvaccinesafterthewithdrawaloforalpoliovaccine
AT dolansamanthab disposingofexcessvaccinesafterthewithdrawaloforalpoliovaccine
AT garonjulie disposingofexcessvaccinesafterthewithdrawaloforalpoliovaccine
AT veirachantallaroche disposingofexcessvaccinesafterthewithdrawaloforalpoliovaccine
AT hamptonleem disposingofexcessvaccinesafterthewithdrawaloforalpoliovaccine
AT changblancdiana disposingofexcessvaccinesafterthewithdrawaloforalpoliovaccine
AT patelmanishm disposingofexcessvaccinesafterthewithdrawaloforalpoliovaccine